• Study on the Effectiveness and Safety of Masitinib and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    France Germany Greece Latvia Slovenia Spain +1
  • Study on Intraperitoneal Treatment with Fosfomycin, Metronidazole, and Molgramostim for Patients with Multi-Quadrant Peritonitis Undergoing Abdominal Surgery

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Denmark
  • Study on the Safety and Immune Response of OVX033 Vaccine for Adults with Sarbecovirus Disease

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    France
  • Study on Zolpidem’s Effects in Patients with Vision Impairments, Disorders of Consciousness, and Neurotypical Volunteers

    Not yet recruiting

    2 1 1
    Belgium
  • Study on Early Measles Immunization with MMR-0 Vaccine for Infants Under 12 Months During a Measles Outbreak

    Not yet recruiting

    3 1 1 1
    The Netherlands
  • Study on the Safety and Effectiveness of Metal Panel Allergens for Diagnosing Allergic Contact Dermatitis and Eczema in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Germany Italy The Netherlands
  • Study on the Impact of Acetylcysteine and Drug Combination on Kidney Function in Living Donor Kidney Transplant Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on COVID-19 Immunity in Immunocompromised Adults Using Raxtozinameran and Bretovameran in Belgium

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study on the Effects of Dexmedetomidine on Brain Fluid Flow and Activity in Patients with Neurodegenerative Diseases, Delirium, or Acute Neurological Conditions

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Finland
  • Study on the Safety and Immune Response of GBS-NN/NN2 and Tdap Vaccines in Preventing Group B Strep Infection in Healthy Women Aged 18-49

    Not yet recruiting

    4 1 1
    Belgium Poland

powered by